Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • Email Alerts
      • Contact IR

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR

Investors

Investors

SHARE PRICE

> View All Stock

  • Detailed Share Information
Latest News
Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM 2023 Annual Meeting
Molecular Partners Reports H1 2023 Corporate Highlights and Financials
Molecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023

> View All News

  • All News
Upcoming Events
More events are coming soon.

> View All Events

  • All Events
Latest Presentation
September 21, 2023
Corporate Presentation - September 2023
August 24, 2023
H1 2023 Results Presentation
May 26, 2023
RBC Healthcare Conference Presentation

> View All Presentations

  • All Presentations
Latest Financial Documents
August 24, 2023
H1 2023 Business Update and Financial Statements
April 19, 2023
Molecular Partners statement regarding Passive Foreign Investment Company status
March 9, 2023
Annual Report FY2022

> View All Reports

  • All Annual Report
Seth Lewis

Seth Lewis,
SVP Investor Relations and Strategy

Contact Seth

STAY INFORMED

Subscribe to email alerts of your choosing

SUBSCRIBE

Institutional investors:

  REQUEST 1-1 / CALL

powered by schedulR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2023 Molecular Partners.